Clozapine Beyond Walls: Community Clozapine Initiation in Early Psychosis

Clozapine is a pharmacological treatment with strong evidence for treatment-resistant schizophrenia (TRS), yet it continues to be under-prescribed, initiated late, and offered to a minority of eligible patients. This treatment gap is felt most acutely in early intervention in psychosis (EIP) services. The accompanying study by Conaty et al. examines the clinico-demographic correlates of community versus hospital clozapine initiation in a first-episode psychosis (FEP) population. Over half of clozapine treated patients were initiated in the community, and this was associated with substantially lower discontinuation rates. This commentary situates those findings within the wider barriers literature in first episode psychosis, considers the emerging role of virtual wards and remote monitoring in facilitating community-based initiation, and outlines implications for service design and future research.